Bausch Health Companies Inc (NYSE: BHC) established initial surge of 10.29% at $7.18, as the Stock market unbolted on Thursday, before settling in for the price of $6.51 at the close. Taking a more long-term approach, BHC posted a 52-week range of $3.96-$11.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 3.30%. Meanwhile, its Annual Earning per share during the time was 52.32%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.93%. This publicly-traded company’s shares outstanding now amounts to $367.80 million, simultaneously with a float of $290.88 million. The organization now has a market capitalization sitting at $2.64 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.43, while the 200-day Moving Average is $7.24.
Bausch Health Companies Inc (BHC) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Bausch Health Companies Inc industry. Bausch Health Companies Inc’s current insider ownership accounts for 20.91%, in contrast to 59.63% institutional ownership. According to the most recent insider trade that took place on Dec 02 ’24, this organization’s EVP, General Counsel sold 440 shares at the rate of 8.35, making the entire transaction reach 3,674 in total value, affecting insider ownership by 433,066.
Bausch Health Companies Inc (BHC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.11 per share during the current fiscal year.
Bausch Health Companies Inc’s EPS increase for this current 12-month fiscal period is 10.93% and is forecasted to reach 4.88 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.08% through the next 5 years, which can be compared against the 52.32% growth it accomplished over the previous five years trading on the market.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
Let’s observe the current performance indicators for Bausch Health Companies Inc (BHC). It’s Quick Ratio in the last reported quarter now stands at 0.82. The Stock has managed to achieve an average true range (ATR) of 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.27. Similarly, its price to free cash flow for trailing twelve months is now 2.54.
In the same vein, BHC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.13, a figure that is expected to reach 0.85 in the next quarter, and analysts are predicting that it will be 4.88 at the market close of one year from today.
Technical Analysis of Bausch Health Companies Inc (BHC)
Now, what If we examine the latest scores posted by [Bausch Health Companies Inc, BHC]. During the last 5-days, its volume was better the volume of 3.42 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.48% While, its Average True Range was 0.35.
Raw Stochastic average of Bausch Health Companies Inc (BHC) in the period of the previous 100 days is set at 28.42%, which indicates a major fall in contrast to 75.18% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 69.49% that was higher than 48.05% volatility it exhibited in the past 100-days period.
